| scholarly article | Q13442814 |
| P356 | DOI | 10.4269/AJTMH.2001.65.414 |
| P698 | PubMed publication ID | 11716092 |
| P50 | author | Brian R. Murphy | Q65658906 |
| P2093 | author name string | R A Karron | |
| S S Whitehead | |||
| D Strickman | |||
| K A Hanley | |||
| J M Troyer | |||
| A P Durbin | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Dengue virus | Q476209 |
| attenuated vaccine | Q1810913 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 414-419 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
| P1476 | title | A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes | |
| P478 | volume | 65 |
| Q27473080 | A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys |
| Q89552802 | A Review on Dengue Vaccine Development |
| Q40553373 | A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4. |
| Q27473379 | American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells |
| Q27490202 | An evolutionary conserved function of the JAK-STAT pathway in anti-dengue defense |
| Q97521587 | Anti-dengue Vaccines: From Development to Clinical Trials |
| Q27485457 | Asymmetric competitive suppression between strains of dengue virus |
| Q27469872 | Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice |
| Q34979371 | Chikungunya virus 3' untranslated region: adaptation to mosquitoes and a population bottleneck as major evolutionary forces |
| Q27469831 | Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile Virus |
| Q35046285 | Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes |
| Q38605190 | Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine. |
| Q42980788 | Core protein-mediated 5'-3' annealing of the West Nile virus genomic RNA in vitro |
| Q57059015 | Decreased accumulation of subgenomic RNA in human cells infected with vaccine candidate DEN4Δ30 increases viral susceptibility to type I interferon |
| Q27485759 | Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development |
| Q27485404 | Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4 |
| Q27488376 | Density-Dependent Competitive Suppression of Sylvatic Dengue Virus by Endemic Dengue Virus in Cultured Mosquito Cells |
| Q35206695 | Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine |
| Q35532741 | Dual miRNA targeting restricts host range and attenuates neurovirulence of flaviviruses |
| Q34580911 | Flavivirus-mosquito interactions |
| Q26700111 | Functions of the 3' and 5' genome RNA regions of members of the genus Flavivirus |
| Q40042772 | Limited Transmission Potential of Takeda's Tetravalent Dengue Vaccine Candidate by Aedes albopictus |
| Q40549292 | Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus |
| Q27472938 | Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes |
| Q27490989 | Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 30-4995 in Healthy Adult Volunteers |
| Q27487377 | Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity |
| Q29619608 | Prospects for a dengue virus vaccine |
| Q60917374 | RNA Structure Duplication in the Dengue Virus 3' UTR: Redundancy or Host Specificity? |
| Q30388555 | RNA interference modulates replication of dengue virus in Drosophila melanogaster cells |
| Q37007003 | Replacement of conserved or variable sequences of the mosquito-borne dengue virus 3' UTR with homologous sequences from Modoc virus does not change infectivity for mosquitoes |
| Q35097570 | Replacement of the 3' untranslated variable region of mosquito-borne dengue virus with that of tick-borne Langat virus does not alter vector specificity |
| Q34766882 | Replacing a native Wolbachia with a novel strain results in an increase in endosymbiont load and resistance to dengue virus in a mosquito vector |
| Q42984608 | Reprint of: Core protein-mediated 5'-3' annealing of the West Nile virus genomic RNA in vitro |
| Q40082112 | Rise and fall of vector infectivity during sequential strain displacements by mosquito-borne dengue virus. |
| Q36181531 | Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults |
| Q40400756 | Role of RNA structures present at the 3'UTR of dengue virus on translation, RNA synthesis, and viral replication |
| Q27469453 | Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus |
| Q27485468 | Superior infectivity for mosquito vectors contributes to competitive displacement among strains of dengue virus |
| Q24288867 | Tackling dengue fever: Current status and challenges |
| Q36118259 | Targeted mutagenesis as a rational approach to dengue virus vaccine development |
| Q32183359 | The 5' and 3' Untranslated Regions of the Flaviviral Genome |
| Q27486384 | The Aedes aegypti Toll Pathway Controls Dengue Virus Infection |
| Q27491318 | The Endosymbiotic Bacterium Wolbachia Induces Resistance to Dengue Virus in Aedes aegypti |
| Q34047962 | The Toll immune signaling pathway control conserved anti-dengue defenses across diverse Ae. aegypti strains and against multiple dengue virus serotypes |
| Q36292728 | The entomopathogenic fungus Beauveria bassiana activate toll and JAK-STAT pathway-controlled effector genes and anti-dengue activity in Aedes aegypti |
| Q26700076 | The tortoise or the hare? Impacts of within-host dynamics on transmission success of arthropod-borne viruses |
| Q35143285 | Traditional and novel approaches to flavivirus vaccines |
| Q37184768 | Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles |
| Q24805308 | Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2 |
| Q27478162 | Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1 |
| Q35172628 | Vaccines for the prevention of neglected diseases--dengue fever |
| Q34359780 | Wolbachia induces density-dependent inhibition to dengue virus in mosquito cells |
| Q24613645 | Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito Aedes aegypti |
Search more.